The global prefilled syringes market attained a value of $1,914.1 million in 2020, and it is predicted to progress at a CAGR of 6.8% between 2021 and 2030. Furthermore, the market is predicted to reach a revenue of $3,646.7 million by 2030. The factors fueling the expansion of the market are the surging concerns raised over the prevalence of needlestick injuries, various advantages of prefilled syringes over conventional vial and syringe packaging systems, and the burgeoning requirement for point-of-care administration.

Additionally, the growing incidence of lifestyle-associated and chronic diseases and the soaring requirement for injectable pharmaceutical products are fueling the expansion of the market. Vaccines and therapeutic agents are some of the major injectable pharmaceutical products that are experiencing a surge in demand. As per the World Health Organization (WHO), nearly 16 billion injections, including 95% for curative care, 2% for contraceptives and blood transfusion procedures, and 3% for immunization are administered across the world every year.

The usage of prefilled syringes is also growing sharply, because of the various benefits of these syringes over multi-dose vials such as simpler drug administration and reduction in drug wastage. Depending on material type, the prefilled syringes market is categorized into plastic-based prefilled syringes and glass-based prefilled syringes. Between these, the glass-based category held the larger share in the market in 2020, due to the fact that these syringes were widely preferred by drug manufacturers.

Browse detailed report on Prefilled Syringes Market Size, Share, Growth and Demand Forecast to 2030

This was because of their ability to prevent reactions between the syringe surface and different drug molecules. However, in the forthcoming years, the plastic-based category is predicted to demonstrate higher growth rate in the market. This will be because of the usage of advanced polymers such as crystal-clear polymer, that are biocompatible with various components of prefilled syringes, and polypropylene for their production. The market is also classified, on the basis of application, into diabetes, anaphylaxis, cancer, and rheumatoid arthritis.

Out of these, the diabetes category held the largest share in the market in 2020, and it is predicted to retain its dominance in the upcoming years as well. Diabetes affects the production of insulin and the ability of the cells to respond appropriately to the insulin produced by the pancreas, which, in turn, disbalances the blood glucose level in the body. Thus, to meet this insulin requirement, diabetics need supplemental insulin, which is primarily taken through syringes.

Globally, Europe contributed the highest revenue to the prefilled syringes market in 2020, because of the high incidence of non-communicable diseases such as cancer, cardiovascular diseases, and diabetes in the region. In the future years, the market will demonstrate the fastest growth in Asia-Pacific, as per the estimates of the market research company, P&S Intelligence. This will be because of the surging healthcare expenditure in the major Asian countries and the growing incidence of chronic diseases in the region.

Get sample pages of this report: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market/report-sample

Therefore, it can be said without any hesitation that the market will boom in the forthcoming years, mainly because of the growing incidence of various non-communicable, chronic, and lifestyle-associated diseases, burgeoning requirement for injectable pharmaceutical products, and the surging geriatric population all over the world.

Prefilled Syringes Market Size Breakdown by Segment

By Type

• Conventional
• Safety

By Material Type

• Glass
• Plastic

By Design

• Single-Chamber
• Dual-Chamber
• Customized

By Application

• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer

By Geography

• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Netherlands
• North America
• U.S.
• Canada
• Asia-Pacific
• Japan
• China
• India
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa
• South Africa
• Saudi Arabia
• U.A.E.

Browse Other Related Reports

Human Insulin Market Report - Geographically, the human insulin market will demonstrate the fastest growth in the Asia-Pacific region in the upcoming years. This will be a result of the increasing urbanization rate and mushrooming geriatric population in regional countries such as India and China.

Auto-Injectors Market Report - Geographically, the auto-injectors market is currently recording the highest growth in North America, as per the findings of P&S Intelligence, a market research firm based in India. In this region, the market is exhibiting the highest growth in the U.S.

Media Contact
Company Name: P&S Intelligence
Contact Person: Abhishek
Email: Send Email
Phone: +918887787886
Address:Noida Sector 2
City: Noida
State: UP
Country: India
Website: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market